Harvard – 6th Annual Update in Neuro-Oncology 2026 (Videos)

Advanced Neuro-Oncology, Brain Tumors, CNS & PNS Neoplasms, Molecular Neuropathology, Neuroimaging & Precision Cancer Care

Stay at the forefront of modern neuro-oncology with the Harvard 6th Annual Update in Neuro-Oncology 2026, an advanced continuing medical education (CME) program providing the latest evidence-based approaches to the diagnosis, classification, treatment, and long-term management of tumors affecting the central nervous system (CNS) and peripheral nervous system (PNS).

Held July 22–24, 2026, this expert-led Harvard Medical School course delivers a comprehensive multidisciplinary review of adult and pediatric neuro-oncology. International faculty present current advances in molecular diagnostics, neurogenetics, neuroradiology, neurosurgery, radiation oncology, systemic therapies, and the management of neurological complications associated with cancer and modern cancer treatments.

Designed for clinicians involved in the care of patients with brain tumors and nervous system malignancies, the course combines practical clinical guidance, contemporary molecular pathology, and evolving therapeutic strategies that can be directly applied to patient care.

Product Details

• Course: Harvard – 6th Annual Update in Neuro-Oncology 2026
• Provider: Harvard Medical School
• Course Dates: July 22–24, 2026
• Format: Videos
• Language: English
• Educational Level: Advanced
• Learning Format: Expert Lectures, Case-Based Discussions, Evidence-Based Clinical Updates

Course Overview

Neuro-oncology has rapidly evolved with major advances in molecular diagnostics, genomic classification, targeted therapies, immunotherapy, precision medicine, and advanced neuroimaging. Accurate diagnosis and multidisciplinary management now require close collaboration among neurologists, oncologists, neurosurgeons, radiation oncologists, neuroradiologists, and neuropathologists.

The 6th Annual Update in Neuro-Oncology 2026 provides a comprehensive review of contemporary management for both pediatric and adult patients with primary and metastatic tumors involving the central and peripheral nervous systems. The curriculum also addresses neurogenetic syndromes, modern molecular neuropathology, advanced neuroradiology, and neurological complications arising from cancer and emerging oncologic therapies.

Faculty emphasize practical implementation of current evidence, evolving classification systems, and personalized treatment approaches to improve outcomes for patients with complex neuro-oncologic disorders.

What You’ll Learn

After completing this course, participants will be able to:

• Apply molecular biomarkers for accurate classification of CNS and PNS tumors.
• Diagnose and manage primary and metastatic brain tumors using current evidence-based strategies.
• Integrate advanced neuroradiology and molecular neuropathology into clinical decision-making.
• Recognize neurological complications associated with modern cancer therapies.
• Develop multidisciplinary treatment plans for adult and pediatric neuro-oncology patients.
• Manage long-term neurological complications following cancer treatment.
• Incorporate emerging precision medicine approaches into neuro-oncology practice.

Comprehensive Topics Covered

Neuro-Oncology

Develop expertise in nervous system tumors.

Topics include:

• Neuro-oncology
• Brain tumors
• CNS tumors
• PNS tumors
• Adult neuro-oncology
• Pediatric neuro-oncology
• Multidisciplinary cancer care

Primary & Metastatic Brain Tumors

Strengthen diagnostic and therapeutic strategies.

Topics include:

• Primary brain tumors
• Metastatic brain tumors
• Gliomas
• Brain metastases
• Intracranial neoplasms
• Treatment planning
• Clinical management

Molecular Neuropathology

Master contemporary tumor classification.

Topics include:

• Molecular biomarkers
• Molecular neuropathology
• Tumor classification
• Precision diagnostics
• Genomic profiling
• WHO classification
• Personalized oncology

Neurogenetic Syndromes

Understand inherited neurological cancers.

Topics include:

• Neurogenetics
• Hereditary tumor syndromes
• Cancer genetics
• Molecular diagnosis
• Genetic counseling
• Risk assessment
• Precision medicine

Neuroradiology

Enhance imaging interpretation.

Topics include:

• Brain MRI
• Advanced neuroimaging
• CNS imaging
• PNS imaging
• Diagnostic imaging
• Imaging biomarkers
• Treatment monitoring

Radiation Oncology

Optimize radiotherapeutic management.

Topics include:

• Radiation therapy
• Stereotactic radiosurgery
• Brain tumor radiation
• Treatment planning
• Radiation complications
• Multidisciplinary care
• Evidence-based practice

Systemic Cancer Therapy

Review modern oncologic treatments.

Topics include:

• Targeted therapy
• Chemotherapy
• Immunotherapy
• Precision oncology
• Systemic treatment
• Combination therapies
• Emerging therapeutics

Neurological Complications of Cancer

Improve recognition and management.

Topics include:

• Neurological complications
• Neurotoxicity
• Treatment-related complications
• Cancer-associated neurological disorders
• Supportive care
• Clinical management
• Survivorship

Long-Term Survivorship

Support patients beyond treatment.

Topics include:

• Long-term complications
• Survivorship
• Rehabilitation
• Cognitive outcomes
• Functional recovery
• Quality of life
• Follow-up care

Learning Objectives

Upon completion of this educational activity, participants will be able to:

• Define the role of molecular biomarkers in the accurate diagnosis and classification of pediatric and adult CNS and PNS tumors.
• Determine current and emerging treatment strategies for primary and metastatic tumors involving the central and peripheral nervous systems.
• Recognize, evaluate, and manage neurological complications associated with contemporary cancer therapies.
• Identify and manage long-term complications resulting from CNS and PNS tumors and their treatments.

Educational Highlights

• Neuro-Oncology
• Brain Tumors
• CNS Tumors
• PNS Tumors
• Molecular Neuropathology
• Molecular Biomarkers
• Precision Medicine
• Neurogenetics
• Neuroradiology
• Brain MRI
• Gliomas
• Brain Metastases
• Radiation Oncology
• Neurosurgery
• Immunotherapy
• Targeted Therapy
• Pediatric Neuro-Oncology
• Adult Neuro-Oncology
• Neurological Complications of Cancer
• Continuing Medical Education (CME)

Why This Course Stands Out

The Harvard 6th Annual Update in Neuro-Oncology 2026 provides a comprehensive multidisciplinary review of one of the fastest-evolving fields in oncology. By integrating molecular pathology, advanced neuroimaging, precision medicine, modern surgical and radiation techniques, and systemic cancer therapies, the course equips clinicians with practical, evidence-based strategies for diagnosing and managing complex tumors of the central and peripheral nervous systems while addressing the neurological consequences of cancer and its treatment.

Target Audience

This educational activity is ideal for:

• Neurologists
• Medical Oncologists
• Radiation Oncologists
• Neurosurgeons
• Neuroradiologists
• Neuropathologists
• Neuro-Oncologists
• Hematology-Oncology Fellows
• Neurology Residents
• Nurse Practitioners
• Physician Assistants
• Oncology Nurses
• Pharmacists
• Psychologists
• Healthcare Professionals involved in neuro-oncology care

Why Choose This Course?

Whether you care for patients with gliomas, metastatic brain tumors, neurogenetic syndromes, or treatment-related neurological complications, the Harvard 6th Annual Update in Neuro-Oncology 2026 offers an outstanding evidence-based review of modern neuro-oncology. Through expert-led lectures and multidisciplinary clinical discussions, participants gain practical knowledge that enhances diagnostic precision, treatment planning, multidisciplinary collaboration, and long-term patient outcomes.

+ Topics:

• Welcome Adult Neuro-Oncology

• Advances in Surgery for Brain Tumors

• Advances in the Imaging of Adult Brain Tumors

• Advances in Radiation for Brain Tumors

• WHO Classification for Adult Gliomas

• Live Question and Answer Session Tracy Batchelor; E. Antonio Chiocca

• Gliomas, IDH-Mutant

• Gliomas, IDH-Wildtype

• Advances in Experimental Therapies for Gliomas

• Meningiomas

• CNS lymphomas

• Pituitary Tumors

• Live Question and Answer Session L. Nicolas Gonzalez Castro; E. Antonio Chiocca

• Live CNS Tumor Board L. Nicolas Gonzalez Castro

• Welcome Neurological Complications of Cancer

• Metastases to the Brain

• Metastases to the Leptomeninges

• Metastases to the Epidural Space and Spinal Cord

• Paraneoplastic Neurological Syndromes

• Live Question and Answer Session Patrick Wen; Tracy Batchelor

• Common Neurological Complications in Cancer Patients

• Neurological Complications of Cancer Immunotherapies

• Survivorship of CNS tumors

• Late Effects of Therapy in Pediatric CNS Tumor Survivors

• Epilepsy and Brain Tumors Towards a Dual-activity Therapy

• Live Question and Answer Session Patrick Wen

• Live CNS Tumor Board Annie Hsieh

• Opening Remarks Pediatric Neuro-Oncology Session

• WHO Classification, Pediatric CNS Tumors

• Advances in the Imaging of Pediatric Brain Tumors

• Embryonal Tumors

• Pediatric Low-Grade Gliomas

• Pediatric High-Grade Gliomas

• Ependymomas

• Live Question and Answer Session Tracy Batchelor; Lissa Baird

• Choroid Plexus Tumors

• Pineal Tumors

• Germ Cell Tumors

• Neurofibromatosis and Schwannomatosis

• Von Hippel Lindau

• Live Question and Answer Session Lissa Baird; Tracy Batchelor

• Live CNS Tumor Board Mariella Filbin; Ralph Salloum; Kee Kiat Yeo

• Closing Statement